1. Home
  2. WETH vs ITRM Comparison

WETH vs ITRM Comparison

Compare WETH & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.36

Market Cap

21.1M

Sector

N/A

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
ITRM
Founded
1992
2015
Country
China
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1M
24.3M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
WETH
ITRM
Price
$1.36
$0.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
126.6K
30.9M
Earning Date
04-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
57.43
EPS
0.32
N/A
Revenue
$45,136,818.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$947.65
P/E Ratio
$4.28
N/A
Revenue Growth
6.76
N/A
52 Week Low
$0.78
$0.03
52 Week High
$3.68
$1.16

Technical Indicators

Market Signals
Indicator
WETH
ITRM
Relative Strength Index (RSI) 35.70 26.10
Support Level $1.26 N/A
Resistance Level $1.46 $0.39
Average True Range (ATR) 0.16 0.02
MACD -0.02 -0.01
Stochastic Oscillator 6.25 3.34

Price Performance

Historical Comparison
WETH
ITRM

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: